GO Term |
GO Name |
Enriched Genes |
Log10 Adjusted P-value |
[BP] GO:0006629 |
lipid metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX12, ALOX15, ALOX5, APP, CBR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, EGFR, EPHX2, ERBB2, FABP3, FABP4, FUT7, HSD11B1, HSD17B1, HSD17B2, MET, MIF, PPARA, TRPV1 |
13.9593 |
[BP] GO:0065008 |
regulation of biological quality
|
ABCB1, ACHE, ADORA1, ADRB1, AKR1B1, ALOX12, ALOX15, APP, AURKB, AXL, BCL2, CA12, CA2, CA7, CACNA1C, CHRM1, CHRM3, CYP19A1, CYP1A1, CYP1B1, CYP3A4, EGFR, EPHX2, FABP3, FABP4, FLT3, HCAR2, HSD11B1, HSD17B1, HSD17B2, KDR, MET, MIF, PPARA, PRKCA, SRC, TNKS, TNKS2, TRPV1, XDH |
10.0023 |
[BP] GO:0033559 |
unsaturated fatty acid metabolic process
|
ALOX12, ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, EPHX2, MIF |
9.90099 |
[BP] GO:0006690 |
icosanoid metabolic process
|
ALOX12, ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, EPHX2, MIF |
9.68349 |
[BP] GO:0019748 |
secondary metabolic process
|
AKR1B1, AKR1B10, BCL2, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, TYR |
9.50335 |
[BP] GO:0019369 |
arachidonic acid metabolic process
|
ALOX12, ALOX15, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, EPHX2 |
9.31016 |
[BP] GO:0044255 |
cellular lipid metabolic process
|
ACHE, AKR1B10, ALOX12, ALOX15, ALOX5, CBR1, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, EGFR, EPHX2, ERBB2, FABP3, FABP4, FUT7, MET, MIF, PPARA |
8.78232 |
[BP] GO:0044281 |
small molecule metabolic process
|
AKR1B1, AKR1B10, ALOX12, ALOX15, ALOX5, APP, CA1, CA12, CA2, CA4, CA7, CA9, CBR1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, EPHX2, FABP3, FUT7, MIF, PIM1, PPARA, TYR, XDH |
8.78232 |
[BP] GO:1901568 |
fatty acid derivative metabolic process
|
ALOX12, ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, EPHX2, MIF |
8.00036 |
[BP] GO:0010647 |
positive regulation of cell communication
|
ADORA1, ADRB1, AKR1B1, ALOX15, APP, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, EGFR, ERBB2, FLT3, HCAR2, KDR, MET, MIF, MMP9, PRKCA, PTPN1, SRC, TNKS, TNKS2, XDH |
7.62239 |
[BP] GO:0023056 |
positive regulation of signaling
|
ADORA1, ADRB1, AKR1B1, ALOX15, APP, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, EGFR, ERBB2, FLT3, HCAR2, KDR, MET, MIF, MMP9, PRKCA, PTPN1, SRC, TNKS, TNKS2, XDH |
7.60745 |
[BP] GO:0006631 |
fatty acid metabolic process
|
ALOX12, ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, EPHX2, FABP3, MIF, PPARA |
7.45248 |
[BP] GO:0008202 |
steroid metabolic process
|
AKR1B1, AKR1B10, APP, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP3A4, HSD11B1, HSD17B1, HSD17B2 |
7.21055 |
[BP] GO:0008152 |
metabolic process
|
ACHE, ADORA1, ADRB1, AKR1B1, AKR1B10, ALOX12, ALOX15, ALOX5, APP, AURKB, AXL, BCL2, CA1, CA12, CA2, CA4, CA7, CA9, CBR1, CDC25B, CHRM1, CHRM3, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, EGFR, EPHX2, ERBB2, FABP3, FABP4, FLT3, FUT7, HSD11B1, HSD17B1, HSD17B2, IGF1R, KDR, MET, MIF, MMP1, MMP2, MMP9, NR3C1, PIM1, PPARA, PRKCA, PTPN1, PTPRS, RORC, SRC, TNKS, TNKS2, TRPV1, TYR, XDH |
7.16538 |
[BP] GO:0001676 |
long-chain fatty acid metabolic process
|
ALOX12, ALOX15, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, EPHX2 |
7.15415 |
[BP] GO:0019373 |
epoxygenase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, EPHX2 |
7.12581 |
[BP] GO:0032502 |
developmental process
|
ACHE, ADORA1, ADRB1, AKR1B1, ALOX15, APP, AURKB, AXL, BCL2, CA2, CA9, CACNA1C, CBR1, CDC25B, CHRM1, CHRM2, CHRM3, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, EGFR, ERBB2, FABP4, FLT3, FUT7, HSD11B1, HSD17B2, KDR, MET, MIF, MMP2, MMP9, PIM1, PPARA, PRKCA, PTPRS, RORC, SRC, TNKS2, TYR |
6.98373 |
[BP] GO:0015701 |
bicarbonate transport
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
6.85006 |
[BP] GO:0042221 |
response to chemical
|
ABCB1, AKR1B1, ALOX15, APP, AXL, BCL2, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, EGFR, EPHX2, ERBB2, FABP3, FABP4, FLT3, HSD17B2, IGF1R, KDR, MMP2, MMP9, NR3C1, PPARA, PRKCA, RORC, SRC, TRPV1, TYR |
6.79444 |
[BP] GO:0010033 |
response to organic substance
|
AKR1B1, ALOX15, APP, AXL, BCL2, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, EGFR, ERBB2, FABP3, FABP4, FLT3, HSD17B2, IGF1R, KDR, MMP2, NR3C1, PPARA, PRKCA, RORC, SRC, TRPV1, TYR |
6.78174 |
[BP] GO:0048518 |
positive regulation of biological process
|
ABCB1, ACHE, ADORA1, ADRB1, AKR1B1, ALOX12, ALOX15, APP, AURKB, AXL, BCL2, CA2, CA7, CDC25B, CHRM1, CHRM3, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, EGFR, EPHX2, ERBB2, FABP3, FABP4, FLT3, HCAR2, IGF1R, KDR, MET, MIF, MMP1, MMP2, MMP9, NR3C1, PIM1, PPARA, PRKCA, PTPN1, RORC, SRC, TNKS, TNKS2, TRPV1, XDH |
6.60514 |
[BP] GO:0010035 |
response to inorganic substance
|
AKR1B1, ALOX15, APP, AXL, BCL2, CA2, CYP1A1, CYP1A2, CYP1B1, EGFR, FABP4, KDR, MMP9, SRC |
6.35772 |
[BP] GO:0007197 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5 |
6.33523 |
[BP] GO:0008283 |
cell proliferation
|
ABCB1, ACHE, AURKB, BCL2, CHRM1, CHRM3, CHRM5, CYP1A1, EGFR, ERBB2, FLT3, MET, MIF, PIM1, SRC, TYR |
6.33228 |
[BP] GO:0032844 |
regulation of homeostatic process
|
ADORA1, AURKB, BCL2, CA2, CA7, CACNA1C, EGFR, HCAR2, KDR, MIF, SRC, TNKS, TNKS2, TRPV1 |
6.26656 |
[BP] GO:0055114 |
oxidation-reduction process
|
AKR1B1, AKR1B10, ALOX12, ALOX15, ALOX5, CBR1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, HSD11B1, HSD17B1, HSD17B2, TYR, XDH |
6.14068 |
[BP] GO:1901700 |
response to oxygen-containing compound
|
AKR1B1, APP, AXL, BCL2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, EGFR, FABP3, HSD17B2, IGF1R, MMP2, MMP9, NR3C1, PPARA, RORC, SRC, TRPV1, TYR |
6.08454 |
[BP] GO:0007207 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5 |
5.95353 |
[BP] GO:0010817 |
regulation of hormone levels
|
ACHE, ADORA1, AKR1B1, CACNA1C, CYP19A1, CYP1A1, CYP1B1, CYP3A4, EGFR, HCAR2, HSD11B1, HSD17B1, HSD17B2, PRKCA |
5.94678 |
[BP] GO:0006730 |
one-carbon metabolic process
|
CA1, CA12, CA2, CA4, CA7, CA9 |
5.86047 |
[BP] GO:0060548 |
negative regulation of cell death
|
ADORA1, AKR1B1, ALOX12, AURKB, AXL, BCL2, CSNK2A1, EGFR, IGF1R, KDR, MET, MIF, MMP9, PIM1, PPARA, PRKCA, PTPN1, SRC |
5.80073 |
[BP] GO:0048522 |
positive regulation of cellular process
|
ACHE, ADORA1, ADRB1, AKR1B1, ALOX12, ALOX15, APP, AURKB, AXL, BCL2, CA2, CA7, CDC25B, CHRM1, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, EGFR, ERBB2, FABP3, FLT3, HCAR2, IGF1R, KDR, MET, MIF, MMP1, MMP2, MMP9, NR3C1, PIM1, PPARA, PRKCA, PTPN1, RORC, SRC, TNKS, TNKS2, TRPV1, XDH |
5.7718 |
[BP] GO:0042127 |
regulation of cell proliferation
|
ADORA1, ADORA3, AKR1B1, ALOX12, APP, BCL2, CDC25B, CHRM1, CSNK2A1, CYP1B1, EGFR, ERBB2, FABP3, FLT3, IGF1R, KDR, MIF, MMP2, MMP9, PIM1, PRKCA, SRC, XDH |
5.75904 |
[BP] GO:0010941 |
regulation of cell death
|
ADORA1, AKR1B1, ALOX12, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, EGFR, FLT3, HCAR2, IGF1R, KDR, MET, MIF, MMP9, PIM1, PPARA, PRKCA, PTPN1, SRC, TRPV1, XDH |
5.74297 |
[BP] GO:0032879 |
regulation of localization
|
ABCB1, ACHE, ADORA1, ADORA3, ALOX12, ALOX15, APP, AXL, BCL2, CA2, CA7, CACNA1C, CHRM1, CSNK2A1, CYP19A1, CYP1B1, EGFR, ERBB2, HCAR2, IGF1R, KDR, MET, MIF, MMP9, PPARA, PRKCA, PTPN1, SRC, TRPV1 |
5.71179 |
[BP] GO:1902533 |
positive regulation of intracellular signal transduction
|
ADORA1, ADRB1, AKR1B1, ALOX15, APP, AXL, BCL2, CYP1B1, EGFR, ERBB2, FLT3, KDR, MET, MIF, PRKCA, PTPN1, SRC, XDH |
5.68 |
[BP] GO:0009967 |
positive regulation of signal transduction
|
ADORA1, ADRB1, AKR1B1, ALOX15, APP, AXL, BCL2, CSNK2A1, CYP1B1, EGFR, ERBB2, FLT3, KDR, MET, MIF, MMP9, PRKCA, PTPN1, SRC, TNKS, TNKS2, XDH |
5.66513 |
[BP] GO:0044237 |
cellular metabolic process
|
ACHE, AKR1B1, AKR1B10, ALOX12, ALOX15, ALOX5, APP, AURKB, AXL, BCL2, CA1, CA12, CA2, CA4, CA7, CA9, CBR1, CDC25B, CHRM1, CHRM3, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, EGFR, EPHX2, ERBB2, FABP3, FABP4, FLT3, FUT7, HSD17B1, HSD17B2, IGF1R, KDR, MET, MIF, MMP1, MMP2, NR3C1, PIM1, PPARA, PRKCA, PTPN1, PTPRS, RORC, SRC, TNKS, TNKS2, TYR, XDH |
5.65905 |
[BP] GO:0043067 |
regulation of programmed cell death
|
ADORA1, AKR1B1, ALOX12, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, EGFR, FLT3, HCAR2, IGF1R, KDR, MET, MIF, MMP9, PIM1, PRKCA, PTPN1, SRC, TRPV1, XDH |
5.65025 |
[BP] GO:0043069 |
negative regulation of programmed cell death
|
ADORA1, AKR1B1, ALOX12, AURKB, AXL, BCL2, CSNK2A1, EGFR, IGF1R, KDR, MET, MIF, MMP9, PIM1, PRKCA, PTPN1, SRC |
5.6304 |
[BP] GO:0032501 |
multicellular organismal process
|
ADORA1, ADRB1, AKR1B1, AKR1B10, ALOX12, ALOX15, ALOX5, APP, AXL, BCL2, CACNA1C, CHRM1, CHRM3, CHRM5, CYP19A1, CYP1A2, CYP1B1, EGFR, EPHX2, FABP4, HSD17B2, IGF1R, MET, MMP1, MMP2, MMP9, PIM1, PPARA, RORC, SRC, TNKS2, TRPV1, TYR |
5.52757 |
[BP] GO:0040012 |
regulation of locomotion
|
ADORA1, ADORA3, ALOX12, APP, BCL2, CHRM1, CYP19A1, CYP1B1, EGFR, ERBB2, IGF1R, KDR, MET, MIF, MMP9, PRKCA, SRC |
5.49275 |
[BP] GO:0051270 |
regulation of cellular component movement
|
ADORA1, ADORA3, ALOX12, APP, BCL2, CACNA1C, CYP19A1, CYP1B1, EGFR, ERBB2, IGF1R, KDR, MET, MIF, MMP9, PRKCA, SRC |
5.4787 |
[BP] GO:0032787 |
None
|
ALOX12, ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, EPHX2, FABP3, MIF, PPARA |
5.41898 |
[BP] GO:0048513 |
animal organ development
|
ACHE, AXL, BCL2, CA2, CACNA1C, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, EGFR, ERBB2, FLT3, HSD11B1, HSD17B2, KDR, PPARA, PTPRS, SRC, TYR |
5.25192 |
[BP] GO:0042445 |
hormone metabolic process
|
ACHE, AKR1B1, CYP19A1, CYP1A1, CYP1B1, CYP3A4, HSD11B1, HSD17B1, HSD17B2 |
5.24014 |
[BP] GO:2000145 |
regulation of cell motility
|
ADORA1, ADORA3, ALOX12, APP, BCL2, CYP19A1, CYP1B1, EGFR, ERBB2, IGF1R, KDR, MET, MIF, MMP9, PRKCA, SRC |
5.18656 |
[BP] GO:0033993 |
response to lipid
|
AXL, BCL2, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, EGFR, FABP3, FLT3, HSD17B2, NR3C1, RORC, SRC, TYR |
5.10867 |
[BP] GO:0042981 |
regulation of apoptotic process
|
ADORA1, AKR1B1, ALOX12, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, EGFR, FLT3, HCAR2, IGF1R, KDR, MIF, MMP9, PIM1, PRKCA, PTPN1, SRC, TRPV1, XDH |
5.08198 |
[BP] GO:0014070 |
response to organic cyclic compound
|
APP, BCL2, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, EGFR, FLT3, NR3C1, RORC, SRC, TRPV1, TYR |
5.08198 |
[BP] GO:0046777 |
protein autophosphorylation
|
AURKB, CSNK2A1, EGFR, ERBB2, FLT3, IGF1R, KDR, PIM1, SRC |
5.05536 |
[BP] GO:0043066 |
negative regulation of apoptotic process
|
ADORA1, AKR1B1, ALOX12, AURKB, AXL, BCL2, CSNK2A1, EGFR, IGF1R, KDR, MIF, MMP9, PIM1, PRKCA, PTPN1, SRC |
4.99454 |
[BP] GO:0009719 |
response to endogenous stimulus
|
AKR1B1, APP, BCL2, CA2, CA9, CSNK2A1, CYP1A2, EGFR, ERBB2, FABP3, FLT3, IGF1R, MMP2, NR3C1, PPARA, SRC, TRPV1 |
4.96126 |
[BP] GO:0008284 |
positive regulation of cell proliferation
|
AKR1B1, ALOX12, BCL2, CDC25B, CHRM1, CSNK2A1, EGFR, ERBB2, FLT3, IGF1R, KDR, MIF, MMP2, MMP9, PIM1, PRKCA |
4.80556 |
[BP] GO:0030334 |
regulation of cell migration
|
ADORA1, ADORA3, ALOX12, APP, BCL2, CYP19A1, CYP1B1, EGFR, IGF1R, KDR, MET, MIF, MMP9, PRKCA, SRC |
4.76667 |
[BP] GO:0072593 |
reactive oxygen species metabolic process
|
ALOX12, BCL2, CYP1A1, CYP1A2, CYP1B1, EGFR, EPHX2 |
4.70267 |
[BP] GO:0042446 |
hormone biosynthetic process
|
AKR1B1, CYP19A1, CYP3A4, HSD11B1, HSD17B1, HSD17B2 |
4.69405 |
[BP] GO:0010646 |
regulation of cell communication
|
ACHE, ADORA1, ADRB1, AKR1B1, ALOX15, APP, AURKB, AXL, BCL2, CA2, CA7, CACNA1C, CSNK2A1, CYP19A1, CYP1B1, EGFR, ERBB2, FLT3, HCAR2, IGF1R, KDR, MET, MIF, MMP9, PRKCA, PTPN1, PTPRS, SRC, TNKS, TNKS2, XDH |
4.67881 |
[BP] GO:0048856 |
anatomical structure development
|
ACHE, ADORA1, AKR1B1, ALOX15, APP, AXL, BCL2, CA2, CACNA1C, CHRM1, CHRM2, CHRM3, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, EGFR, ERBB2, FLT3, HSD11B1, HSD17B2, KDR, MMP9, PIM1, PPARA, PTPRS, RORC, SRC, TYR |
4.57204 |
[BP] GO:0023051 |
regulation of signaling
|
ACHE, ADORA1, ADRB1, AKR1B1, ALOX15, APP, AURKB, AXL, BCL2, CA2, CA7, CACNA1C, CSNK2A1, CYP19A1, CYP1B1, EGFR, ERBB2, FLT3, HCAR2, IGF1R, KDR, MET, MIF, MMP9, PRKCA, PTPN1, PTPRS, SRC, TNKS, TNKS2, XDH |
4.56617 |
[BP] GO:0034754 |
cellular hormone metabolic process
|
AKR1B1, CYP19A1, CYP1A1, CYP1B1, CYP3A4, HSD17B1, HSD17B2 |
4.56393 |
[BP] GO:0070887 |
cellular response to chemical stimulus
|
AKR1B1, ALOX15, APP, AXL, BCL2, CYP1A1, CYP1A2, CYP1B1, EGFR, ERBB2, FABP4, FLT3, IGF1R, KDR, MMP2, MMP9, NR3C1, RORC, SRC, TRPV1 |
4.54188 |
[BP] GO:0044238 |
primary metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX12, ALOX15, ALOX5, APP, AURKB, AXL, BCL2, CBR1, CDC25B, CHRM1, CHRM3, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, EGFR, EPHX2, ERBB2, FABP3, FABP4, FLT3, FUT7, HSD11B1, HSD17B1, HSD17B2, IGF1R, KDR, MET, MIF, MMP1, MMP2, MMP9, NR3C1, PIM1, PPARA, PRKCA, PTPN1, PTPRS, RORC, SRC, TNKS, TNKS2, TRPV1, TYR, XDH |
4.53903 |
[BP] GO:0006468 |
protein phosphorylation
|
APP, AURKB, AXL, BCL2, CDC25B, CSNK2A1, EGFR, ERBB2, FLT3, IGF1R, KDR, MET, PIM1, PRKCA, SRC, TNKS |
4.53105 |
[BP] GO:1902531 |
regulation of intracellular signal transduction
|
ADORA1, ADRB1, AKR1B1, ALOX15, APP, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, EGFR, ERBB2, FLT3, IGF1R, KDR, MET, MIF, MMP9, PRKCA, PTPN1, SRC, XDH |
4.47192 |
[BP] GO:0071310 |
cellular response to organic substance
|
AKR1B1, ALOX15, APP, AXL, BCL2, CYP1A1, CYP1B1, EGFR, ERBB2, FABP4, FLT3, IGF1R, KDR, MMP2, NR3C1, RORC, SRC, TRPV1 |
4.46564 |
[BP] GO:0042592 |
homeostatic process
|
ADORA1, ADRB1, AKR1B1, ALOX12, APP, AXL, BCL2, CA12, CA2, CA7, CACNA1C, EGFR, EPHX2, FABP3, FABP4, FLT3, MET, SRC, TRPV1 |
4.46537 |
[BP] GO:0006805 |
xenobiotic metabolic process
|
CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP3A4, EPHX2, RORC |
4.45213 |
[BP] GO:0007169 |
transmembrane receptor protein tyrosine kinase signaling pathway
|
AXL, EGFR, ERBB2, FLT3, IGF1R, KDR, MET, MMP2, MMP9, PRKCA, PTPN1, SRC |
4.4499 |
[BP] GO:0032847 |
regulation of cellular pH reduction
|
BCL2, CA2, CA7 |
4.41922 |
[BP] GO:0048584 |
positive regulation of response to stimulus
|
ADORA1, ADRB1, AKR1B1, ALOX15, APP, AXL, BCL2, CSNK2A1, CYP1B1, EGFR, ERBB2, FABP4, FLT3, KDR, MET, MIF, MMP2, MMP9, PRKCA, PTPN1, SRC, TNKS, TNKS2, XDH |
4.41922 |
[BP] GO:0010562 |
positive regulation of phosphorus metabolic process
|
ADORA1, ADRB1, ALOX15, APP, BCL2, CDC25B, EGFR, ERBB2, FABP3, FLT3, KDR, MIF, MMP9, PRKCA, PTPN1, SRC, XDH |
4.38204 |
[BP] GO:0045937 |
positive regulation of phosphate metabolic process
|
ADORA1, ADRB1, ALOX15, APP, BCL2, CDC25B, EGFR, ERBB2, FABP3, FLT3, KDR, MIF, MMP9, PRKCA, PTPN1, SRC, XDH |
4.38204 |
[BP] GO:0043410 |
positive regulation of MAPK cascade
|
ADORA1, ALOX15, APP, EGFR, ERBB2, FLT3, KDR, MIF, PRKCA, PTPN1, SRC, XDH |
4.37028 |
[BP] GO:1901615 |
organic hydroxy compound metabolic process
|
AKR1B1, AKR1B10, ALOX12, ALOX15, APP, BCL2, CYP19A1, CYP1A1, CYP1B1, CYP3A4, TYR |
4.37028 |
[BP] GO:0051049 |
regulation of transport
|
ABCB1, ACHE, ADORA1, ALOX15, APP, AXL, BCL2, CA2, CA7, CACNA1C, CHRM1, CYP19A1, EGFR, ERBB2, HCAR2, MIF, MMP9, PPARA, PRKCA, PTPN1, SRC, TRPV1 |
4.37028 |
[BP] GO:0009611 |
response to wounding
|
ACHE, ADORA3, ALOX15, BCL2, CYP1A1, EGFR, ERBB2, PPARA |
4.34028 |
[BP] GO:0015711 |
organic anion transport
|
ABCB1, CA1, CA12, CA14, CA2, CA4, CA7, CA9, FABP3, PPARA, TRPV1 |
4.33962 |
[BP] GO:0019752 |
carboxylic acid metabolic process
|
ALOX12, ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, EPHX2, FABP3, MIF, PIM1, PPARA, TYR |
4.31321 |
[BP] GO:0007213 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5 |
4.2936 |
[BP] GO:0018108 |
peptidyl-tyrosine phosphorylation
|
AXL, EGFR, ERBB2, FLT3, IGF1R, KDR, MET, SRC |
4.23357 |
[BP] GO:0019220 |
regulation of phosphate metabolic process
|
ADORA1, ADRB1, ALOX15, APP, BCL2, CDC25B, CHRM5, EGFR, ERBB2, FABP3, FABP4, FLT3, IGF1R, KDR, MIF, MMP9, PPARA, PRKCA, PTPN1, SRC, XDH |
4.22527 |
[BP] GO:0018212 |
peptidyl-tyrosine modification
|
AXL, EGFR, ERBB2, FLT3, IGF1R, KDR, MET, SRC |
4.18857 |
[BP] GO:0051174 |
regulation of phosphorus metabolic process
|
ADORA1, ADRB1, ALOX15, APP, BCL2, CDC25B, CHRM5, EGFR, ERBB2, FABP3, FABP4, FLT3, IGF1R, KDR, MIF, MMP9, PPARA, PRKCA, PTPN1, SRC, XDH |
4.17507 |
[BP] GO:0009725 |
response to hormone
|
AKR1B1, BCL2, CA2, CA9, CSNK2A1, CYP1A2, EGFR, FABP3, FLT3, NR3C1, PPARA, SRC, TRPV1 |
4.08009 |
[BP] GO:0008610 |
lipid biosynthetic process
|
ACHE, AKR1B1, ALOX12, ALOX15, CSNK2A1, CYP19A1, CYP1A1, CYP3A4, HSD11B1, HSD17B1, HSD17B2, MIF |
4.05718 |
[BP] GO:0070372 |
regulation of ERK1 and ERK2 cascade
|
ALOX15, APP, EGFR, ERBB2, KDR, MIF, PRKCA, PTPN1, SRC |
4.03434 |
[BP] GO:0051239 |
regulation of multicellular organismal process
|
ADORA1, ADORA3, ADRB1, ALOX12, APP, AXL, BCL2, CA2, CACNA1C, CHRM1, CHRM2, CHRM3, CYP1B1, EGFR, ERBB2, HCAR2, KDR, MET, MIF, MMP9, PIM1, PRKCA, PTPRS, SRC, TNKS2, TRPV1, XDH |
4.02798 |
[BP] GO:0006796 |
phosphate-containing compound metabolic process
|
ACHE, ALOX15, APP, AURKB, AXL, BCL2, CDC25B, CSNK2A1, EGFR, EPHX2, ERBB2, FLT3, IGF1R, KDR, MET, PIM1, PRKCA, PTPN1, PTPRS, SRC, TNKS, XDH |
4.02798 |
[BP] GO:0019216 |
regulation of lipid metabolic process
|
ADORA1, CHRM5, CYP1A1, EPHX2, FABP3, FLT3, HCAR2, PPARA, RORC, SRC |
4.00847 |
[BP] GO:0071704 |
organic substance metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX12, ALOX15, ALOX5, APP, AURKB, AXL, BCL2, CBR1, CDC25B, CHRM1, CHRM3, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, EGFR, EPHX2, ERBB2, FABP3, FABP4, FLT3, FUT7, HSD11B1, HSD17B1, HSD17B2, IGF1R, KDR, MET, MIF, MMP1, MMP2, MMP9, NR3C1, PIM1, PPARA, PRKCA, PTPN1, PTPRS, RORC, SRC, TNKS, TNKS2, TRPV1, TYR, XDH |
3.98708 |
[BP] GO:2000021 |
regulation of ion homeostasis
|
ADORA1, BCL2, CA2, CA7, CACNA1C, KDR, SRC, TRPV1 |
3.91796 |
[BP] GO:0032845 |
None
|
ADORA1, BCL2, MIF, SRC, TNKS, TNKS2, TRPV1 |
3.8833 |
[BP] GO:0007165 |
signal transduction
|
ADORA1, ADORA3, ADRB1, AKR1B1, APP, AXL, BCL2, CA1, CA2, CACNA1C, CHRM1, CHRM2, CHRM3, CHRM5, CSNK2A1, CYP1B1, EGFR, ERBB2, FLT3, HCAR2, IGF1R, KDR, MET, MIF, MMP2, MMP9, NR3C1, PIM1, PPARA, PRKCA, PTPN1, RORC, SRC, TNKS, TNKS2, TRPV1 |
3.85164 |
[BP] GO:0001934 |
positive regulation of protein phosphorylation
|
ADORA1, ALOX15, APP, BCL2, CDC25B, EGFR, ERBB2, FLT3, KDR, MIF, MMP9, PRKCA, PTPN1, SRC, XDH |
3.84837 |
[BP] GO:2001300 |
lipoxin metabolic process
|
ALOX12, ALOX15, ALOX5 |
3.84382 |
[BP] GO:0043436 |
oxoacid metabolic process
|
ALOX12, ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, EPHX2, FABP3, MIF, PIM1, PPARA, TYR |
3.84382 |
[BP] GO:0051050 |
positive regulation of transport
|
ABCB1, ACHE, ADORA1, APP, AXL, BCL2, CA2, CHRM1, CYP19A1, EGFR, ERBB2, HCAR2, MIF, SRC, TRPV1 |
3.76494 |
[BP] GO:0050896 |
response to stimulus
|
ABCB1, ACHE, ADORA1, ADORA3, ADRB1, AKR1B1, ALOX15, APP, AURKB, AXL, BCL2, CA2, CA9, CHRM2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, EGFR, EPHX2, ERBB2, FABP3, FABP4, FLT3, HSD17B2, IGF1R, KDR, MIF, MMP2, MMP9, NR3C1, PPARA, PRKCA, PTPN1, RORC, SRC, TRPV1, TYR |
3.76494 |
[BP] GO:0006082 |
organic acid metabolic process
|
ALOX12, ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, EPHX2, FABP3, MIF, PIM1, PPARA, TYR |
3.75748 |
[BP] GO:0006793 |
phosphorus metabolic process
|
ACHE, ALOX15, APP, AURKB, AXL, BCL2, CDC25B, CSNK2A1, EGFR, EPHX2, ERBB2, FLT3, IGF1R, KDR, MET, PIM1, PRKCA, PTPN1, PTPRS, SRC, TNKS, XDH |
3.73729 |
[BP] GO:0043408 |
regulation of MAPK cascade
|
ADORA1, ALOX15, APP, EGFR, ERBB2, FLT3, IGF1R, KDR, MIF, PRKCA, PTPN1, SRC, XDH |
3.7332 |
[BP] GO:0095500 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5 |
3.71634 |
[BP] GO:1903831 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5 |
3.71634 |
[BP] GO:0003018 |
None
|
ADORA1, ADRB1, CHRM1, CHRM3, EGFR, EPHX2, SRC |
3.71209 |
[BP] GO:0042327 |
positive regulation of phosphorylation
|
ADORA1, ALOX15, APP, BCL2, CDC25B, EGFR, ERBB2, FLT3, KDR, MIF, MMP9, PRKCA, PTPN1, SRC, XDH |
3.65109 |
[BP] GO:0008210 |
estrogen metabolic process
|
CYP19A1, CYP1B1, HSD17B1, HSD17B2 |
3.65109 |
[BP] GO:0009698 |
phenylpropanoid metabolic process
|
CYP1A1, CYP2A13, CYP2A6 |
3.64805 |
[BP] GO:0009804 |
coumarin metabolic process
|
CYP1A1, CYP2A13, CYP2A6 |
3.64805 |
[BP] GO:0051716 |
cellular response to stimulus
|
AKR1B1, ALOX15, APP, AURKB, AXL, BCL2, CA2, CA9, CYP1A1, CYP1A2, CYP1B1, EGFR, ERBB2, FABP4, FLT3, IGF1R, KDR, MIF, MMP2, MMP9, NR3C1, PTPN1, RORC, SRC, TRPV1 |
3.6472 |
[BP] GO:0042493 |
response to drug
|
ABCB1, AKR1B1, AXL, BCL2, CA9, CYP1A1, CYP1B1, EGFR, FABP3, KDR, NR3C1, SRC, TRPV1 |
3.64535 |
[BP] GO:0010038 |
response to metal ion
|
ALOX15, APP, BCL2, CA2, CYP1A1, CYP1A2, EGFR, FABP4, MMP9 |
3.59032 |
[BP] GO:0044057 |
None
|
ADORA1, ADORA3, ADRB1, CACNA1C, CHRM1, CHRM2, CHRM3, EGFR, HCAR2, PRKCA, TRPV1 |
3.56629 |
[BP] GO:0016310 |
phosphorylation
|
APP, AURKB, AXL, BCL2, CDC25B, CSNK2A1, EGFR, ERBB2, FLT3, IGF1R, KDR, MET, PIM1, PRKCA, SRC, TNKS |
3.55778 |
[BP] GO:0006721 |
terpenoid metabolic process
|
AKR1B10, CYP1A1, CYP1A2, CYP1B1, CYP3A4, EGFR |
3.51469 |
[BP] GO:0017144 |
drug metabolic process
|
ACHE, AKR1B1, AKR1B10, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP3A4, EGFR, EPHX2 |
3.50293 |
[BP] GO:0034614 |
cellular response to reactive oxygen species
|
AKR1B1, AXL, CYP1B1, EGFR, MMP9, SRC |
3.49689 |
[BP] GO:0009893 |
positive regulation of metabolic process
|
ADORA1, ADRB1, ALOX15, APP, AURKB, BCL2, CDC25B, CSNK2A1, EGFR, EPHX2, ERBB2, FABP3, FLT3, IGF1R, KDR, MET, MIF, MMP9, NR3C1, PPARA, PRKCA, PTPN1, RORC, SRC, TNKS, TNKS2, TRPV1, XDH |
3.47942 |
[BP] GO:0007271 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5 |
3.4786 |
[BP] GO:0048519 |
negative regulation of biological process
|
ACHE, ADORA1, ADORA3, ADRB1, AKR1B1, ALOX12, ALOX15, APP, AURKB, AXL, BCL2, CSNK2A1, CYP19A1, CYP1B1, EGFR, ERBB2, FABP3, FABP4, HCAR2, IGF1R, KDR, MET, MIF, MMP9, NR3C1, PIM1, PPARA, PRKCA, PTPN1, PTPRS, RORC, SRC, TNKS, TNKS2, TRPV1, XDH |
3.43399 |
[BP] GO:0000302 |
response to reactive oxygen species
|
AKR1B1, AXL, BCL2, CYP1B1, EGFR, MMP9, SRC |
3.43399 |
[BP] GO:0007166 |
cell surface receptor signaling pathway
|
ADORA1, ADORA3, APP, AXL, BCL2, CA1, CSNK2A1, EGFR, ERBB2, FLT3, IGF1R, KDR, MET, MIF, MMP2, MMP9, PRKCA, PTPN1, SRC, TNKS, TNKS2, TRPV1 |
3.4327 |
[BP] GO:0006820 |
anion transport
|
ABCB1, CA1, CA12, CA14, CA2, CA4, CA7, CA9, FABP3, PPARA, TRPV1 |
3.39312 |
[BP] GO:0051173 |
positive regulation of nitrogen compound metabolic process
|
ADORA1, ADRB1, ALOX15, APP, AURKB, BCL2, CDC25B, CSNK2A1, EGFR, ERBB2, FLT3, IGF1R, KDR, MET, MIF, MMP9, NR3C1, PPARA, PRKCA, PTPN1, RORC, SRC, TNKS, TNKS2, TRPV1, XDH |
3.38143 |
[BP] GO:0042325 |
regulation of phosphorylation
|
ADORA1, ALOX15, APP, BCL2, CDC25B, EGFR, ERBB2, FABP4, FLT3, IGF1R, KDR, MIF, MMP9, PPARA, PRKCA, PTPN1, SRC, XDH |
3.37739 |
[BP] GO:0009056 |
catabolic process
|
ACHE, ADORA1, AKR1B10, AURKB, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP3A4, EPHX2, FABP3, FABP4, FUT7, MMP1, MMP2, MMP9, SRC, XDH |
3.37739 |
[BP] GO:0030335 |
positive regulation of cell migration
|
ALOX12, APP, BCL2, EGFR, IGF1R, KDR, MET, MMP9, PRKCA, SRC |
3.36947 |
[BP] GO:0007167 |
enzyme linked receptor protein signaling pathway
|
AXL, EGFR, ERBB2, FLT3, IGF1R, KDR, MET, MMP2, MMP9, PRKCA, PTPN1, SRC |
3.32044 |
[BP] GO:0048871 |
multicellular organismal homeostasis
|
ADORA1, ADRB1, AKR1B1, ALOX12, MET, TRPV1 |
3.31944 |
[BP] GO:0071407 |
cellular response to organic cyclic compound
|
APP, CYP1A1, CYP1B1, EGFR, FLT3, NR3C1, RORC, SRC, TRPV1 |
3.31455 |
[BP] GO:0051240 |
positive regulation of multicellular organismal process
|
ADRB1, ALOX12, APP, AXL, BCL2, CA2, CHRM3, CYP1B1, EGFR, HCAR2, KDR, MET, MIF, MMP9, PIM1, PRKCA, SRC, TRPV1 |
3.28892 |
[BP] GO:0001932 |
regulation of protein phosphorylation
|
ADORA1, ALOX15, APP, BCL2, CDC25B, EGFR, ERBB2, FABP4, FLT3, IGF1R, KDR, MIF, MMP9, PRKCA, PTPN1, SRC, XDH |
3.28074 |
[BP] GO:2000147 |
positive regulation of cell motility
|
ALOX12, APP, BCL2, EGFR, IGF1R, KDR, MET, MMP9, PRKCA, SRC |
3.26887 |
[BP] GO:0048878 |
chemical homeostasis
|
AKR1B1, ALOX12, APP, BCL2, CA12, CA2, CA7, CACNA1C, EGFR, EPHX2, FABP3, FABP4, MET, TRPV1 |
3.26787 |
[BP] GO:0090087 |
None
|
ACHE, ADORA1, APP, CA2, CACNA1C, CHRM1, EGFR, ERBB2, HCAR2, MIF, PRKCA, PTPN1, SRC |
3.26643 |
[BP] GO:0016042 |
lipid catabolic process
|
ADORA1, AKR1B10, CYP19A1, CYP1A2, CYP1B1, CYP3A4, FABP3, FABP4 |
3.24255 |
[BP] GO:0097746 |
None
|
ADORA1, ADRB1, CHRM1, CHRM3, EGFR, EPHX2 |
3.23255 |
[BP] GO:0035296 |
None
|
ADORA1, ADRB1, CHRM1, CHRM3, EGFR, EPHX2 |
3.23255 |
[BP] GO:2001225 |
regulation of chloride transport
|
ABCB1, CA2, CA7 |
3.23255 |
[BP] GO:0097267 |
omega-hydroxylase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1 |
3.23255 |
[BP] GO:0006720 |
isoprenoid metabolic process
|
AKR1B10, CYP1A1, CYP1A2, CYP1B1, CYP3A4, EGFR |
3.21654 |
[BP] GO:0006694 |
steroid biosynthetic process
|
AKR1B1, CYP19A1, CYP3A4, HSD11B1, HSD17B1, HSD17B2 |
3.20205 |
[BP] GO:0051272 |
positive regulation of cellular component movement
|
ALOX12, APP, BCL2, EGFR, IGF1R, KDR, MET, MMP9, PRKCA, SRC |
3.19284 |
[BP] GO:0070374 |
positive regulation of ERK1 and ERK2 cascade
|
ALOX15, APP, EGFR, KDR, MIF, PRKCA, SRC |
3.16689 |
[BP] GO:0031325 |
positive regulation of cellular metabolic process
|
ADORA1, ADRB1, ALOX15, APP, AURKB, BCL2, CDC25B, EGFR, ERBB2, FABP3, FLT3, IGF1R, KDR, MET, MIF, MMP9, NR3C1, PPARA, PRKCA, PTPN1, RORC, SRC, TNKS, TNKS2, TRPV1, XDH |
3.15509 |
[BP] GO:0035690 |
cellular response to drug
|
AKR1B1, AXL, CYP1B1, EGFR, KDR, NR3C1, SRC, TRPV1 |
3.13214 |
[BP] GO:1903522 |
None
|
ADORA1, ADORA3, ADRB1, CACNA1C, CHRM1, CHRM2, CHRM3, EGFR |
3.10973 |
[BP] GO:0048583 |
regulation of response to stimulus
|
ABCB1, ADORA1, ADRB1, AKR1B1, ALOX12, ALOX15, APP, AURKB, AXL, BCL2, CSNK2A1, CYP19A1, CYP1B1, EGFR, ERBB2, FABP4, FLT3, IGF1R, KDR, MET, MIF, MMP2, MMP9, PPARA, PRKCA, PTPN1, PTPRS, SRC, TNKS, TNKS2, XDH |
3.10973 |
[BP] GO:0050880 |
None
|
ADORA1, ADRB1, CHRM1, CHRM3, EGFR, EPHX2 |
3.10973 |
[BP] GO:0007193 |
None
|
ADORA1, CHRM1, CHRM2, CHRM3, CHRM5 |
3.10811 |
[BP] GO:0035150 |
None
|
ADORA1, ADRB1, CHRM1, CHRM3, EGFR, EPHX2 |
3.09526 |
[BP] GO:0040017 |
positive regulation of locomotion
|
ALOX12, APP, BCL2, EGFR, IGF1R, KDR, MET, MMP9, PRKCA, SRC |
3.08466 |
[BP] GO:0003013 |
None
|
ADORA1, ADRB1, CHRM1, CHRM3, EGFR, EPHX2, SRC |
3.08254 |
[BP] GO:0043393 |
regulation of protein binding
|
APP, AURKB, BCL2, MET, MMP9, PPARA, SRC |
3.08254 |
[BP] GO:0009987 |
cellular process
|
ABCB1, ACHE, ADORA1, ADORA3, ADRB1, AKR1B1, AKR1B10, ALOX12, ALOX15, ALOX5, APP, AURKB, AXL, BCL2, CA1, CA12, CA2, CA4, CA7, CA9, CACNA1C, CBR1, CDC25B, CHRM1, CHRM2, CHRM3, CHRM5, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, EGFR, EPHX2, ERBB2, FABP3, FABP4, FLT3, FUT7, HCAR2, HSD17B1, HSD17B2, IGF1R, KDR, MET, MIF, MMP1, MMP2, MMP9, NR3C1, PIM1, PPARA, PRKCA, PTPN1, PTPRS, RORC, SRC, TNKS, TNKS2, TRPV1, TUBB3, TYR, XDH |
3.07657 |
[BP] GO:0046456 |
icosanoid biosynthetic process
|
ALOX12, ALOX15, ALOX5, MIF |
3.04233 |
[BP] GO:0009628 |
response to abiotic stimulus
|
ADORA1, ADRB1, AKR1B1, APP, AURKB, BCL2, CA2, CYP1A1, EGFR, MMP2, PPARA, SRC, TRPV1, TYR |
3.03345 |
[BP] GO:0042738 |
exogenous drug catabolic process
|
CYP1A2, CYP2A6, CYP3A4 |
3.02502 |
[BP] GO:0080134 |
regulation of response to stress
|
ABCB1, ADORA1, ALOX12, APP, CYP19A1, EGFR, FABP4, IGF1R, MET, MIF, MMP2, PPARA, PRKCA, PTPN1, PTPRS, SRC, XDH |
3.02084 |
[BP] GO:0048523 |
negative regulation of cellular process
|
ACHE, ADORA1, ADORA3, AKR1B1, ALOX12, APP, AURKB, AXL, BCL2, CSNK2A1, CYP19A1, CYP1B1, EGFR, ERBB2, FABP3, FABP4, IGF1R, KDR, MET, MIF, MMP9, NR3C1, PIM1, PPARA, PRKCA, PTPN1, PTPRS, RORC, SRC, TNKS, TNKS2, TRPV1, XDH |
3.01425 |
[BP] GO:0018193 |
peptidyl-amino acid modification
|
AURKB, AXL, BCL2, CSNK2A1, EGFR, ERBB2, FLT3, IGF1R, KDR, MET, PRKCA, SRC, TNKS |
2.97745 |
[BP] GO:0044070 |
regulation of anion transport
|
ABCB1, ADORA1, CA2, CA7, MIF |
2.97551 |
[BP] GO:0038128 |
None
|
EGFR, ERBB2, PRKCA, SRC |
2.96956 |
[BP] GO:0044092 |
negative regulation of molecular function
|
ADORA3, APP, AURKB, CSNK2A1, CYP1B1, FABP4, IGF1R, MET, MMP9, PIM1, PPARA, PRKCA, PTPN1, SRC, TNKS |
2.96956 |
[BP] GO:1901701 |
cellular response to oxygen-containing compound
|
AKR1B1, APP, AXL, CYP1B1, EGFR, IGF1R, MMP2, MMP9, NR3C1, RORC, SRC, TRPV1 |
2.93963 |
[BP] GO:0006703 |
estrogen biosynthetic process
|
CYP19A1, HSD17B1, HSD17B2 |
2.93066 |
[BP] GO:2001301 |
lipoxin biosynthetic process
|
ALOX12, ALOX15 |
2.91966 |
[BP] GO:2001302 |
lipoxin A4 metabolic process
|
ALOX12, ALOX15 |
2.91966 |
[BP] GO:2001303 |
lipoxin A4 biosynthetic process
|
ALOX12, ALOX15 |
2.91966 |
[BP] GO:0071248 |
cellular response to metal ion
|
ALOX15, CYP1A1, CYP1A2, EGFR, FABP4, MMP9 |
2.87712 |
[BP] GO:0032846 |
positive regulation of homeostatic process
|
AURKB, CA2, CA7, EGFR, HCAR2, TNKS, TNKS2 |
2.85003 |
[BP] GO:0031401 |
positive regulation of protein modification process
|
ADORA1, ALOX15, APP, BCL2, CDC25B, EGFR, ERBB2, FLT3, KDR, MIF, MMP9, PRKCA, PTPN1, SRC, XDH |
2.80737 |
[BP] GO:0050730 |
None
|
ADORA1, APP, EGFR, FLT3, MIF, PTPN1, SRC |
2.79443 |
[BP] GO:0007188 |
None
|
ADORA1, ADRB1, CHRM1, CHRM2, CHRM3, CHRM5 |
2.75876 |
[BP] GO:2001243 |
negative regulation of intrinsic apoptotic signaling pathway
|
BCL2, MIF, MMP9, PTPN1, SRC |
2.69728 |
[BP] GO:0038083 |
peptidyl-tyrosine autophosphorylation
|
EGFR, IGF1R, KDR, SRC |
2.67446 |
[BP] GO:1901617 |
organic hydroxy compound biosynthetic process
|
AKR1B1, ALOX12, ALOX15, CYP19A1, CYP3A4, TYR |
2.67316 |
[BP] GO:0019372 |
lipoxygenase pathway
|
ALOX12, ALOX15, ALOX5 |
2.67316 |
[BP] GO:0030258 |
lipid modification
|
ALOX12, CYP1A1, CYP3A4, EGFR, EPHX2, ERBB2, MET |
2.66615 |
[BP] GO:0071363 |
cellular response to growth factor stimulus
|
APP, EGFR, ERBB2, KDR, NR3C1, SRC, TRPV1 |
2.64704 |
[BP] GO:0043405 |
regulation of MAP kinase activity
|
ADORA1, EGFR, ERBB2, FLT3, IGF1R, MIF, PTPN1, SRC |
2.63656 |
[BP] GO:1901184 |
None
|
ADORA1, APP, EGFR, ERBB2, MMP9 |
2.62544 |
[BP] GO:0001775 |
cell activation
|
ALOX5, APP, AXL, BCL2, EGFR, FLT3, FUT7, MIF, MMP9, PRKCA, RORC, SRC, TRPV1 |
2.62057 |
[BP] GO:0006979 |
response to oxidative stress
|
AKR1B1, APP, AXL, BCL2, CYP1B1, EGFR, MMP9, SRC |
2.61664 |
[BP] GO:0051098 |
regulation of binding
|
APP, AURKB, BCL2, MET, MMP9, PPARA, SRC, TNKS |
2.61664 |
[BP] GO:1904355 |
positive regulation of telomere capping
|
AURKB, TNKS, TNKS2 |
2.60646 |
[BP] GO:0070201 |
None
|
ACHE, APP, BCL2, CACNA1C, CHRM1, EGFR, ERBB2, HCAR2, MIF, PRKCA, PTPN1, SRC |
2.6039 |
[BP] GO:0010604 |
positive regulation of macromolecule metabolic process
|
ADORA1, ALOX15, APP, AURKB, BCL2, CDC25B, CSNK2A1, EGFR, EPHX2, ERBB2, FLT3, IGF1R, KDR, MET, MIF, MMP9, NR3C1, PPARA, PRKCA, PTPN1, RORC, SRC, TNKS, TNKS2, XDH |
2.57215 |
[BP] GO:0071241 |
cellular response to inorganic substance
|
ALOX15, CYP1A1, CYP1A2, EGFR, FABP4, MMP9 |
2.5507 |
[BP] GO:0009966 |
regulation of signal transduction
|
ADORA1, ADRB1, AKR1B1, ALOX15, APP, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, EGFR, ERBB2, FLT3, IGF1R, KDR, MET, MIF, MMP9, PRKCA, PTPN1, PTPRS, SRC, TNKS, TNKS2, XDH |
2.53784 |
[BP] GO:0044236 |
multicellular organism metabolic process
|
ADRB1, MMP1, MMP2, MMP9, TRPV1 |
2.50397 |
[BP] GO:0032210 |
regulation of telomere maintenance via telomerase
|
AURKB, SRC, TNKS, TNKS2 |
2.50397 |
[BP] GO:1900673 |
olefin metabolic process
|
CYP1A1, EPHX2 |
2.50397 |
[BP] GO:0032849 |
positive regulation of cellular pH reduction
|
CA2, CA7 |
2.50397 |
[BP] GO:1901654 |
None
|
AKR1B1, CA9, CSNK2A1, EGFR, NR3C1, SRC |
2.48459 |
[BP] GO:0065009 |
regulation of molecular function
|
ABCB1, ADORA1, ADORA3, ADRB1, APP, AURKB, BCL2, CDC25B, CSNK2A1, CYP1B1, EGFR, ERBB2, FABP4, FLT3, IGF1R, MET, MIF, MMP9, PIM1, PPARA, PRKCA, PTPN1, SRC, TNKS, TRPV1, XDH |
2.48356 |
[BP] GO:0051900 |
regulation of mitochondrial depolarization
|
BCL2, KDR, SRC |
2.48356 |
[BP] GO:0043406 |
positive regulation of MAP kinase activity
|
ADORA1, EGFR, ERBB2, FLT3, MIF, PTPN1, SRC |
2.48356 |
[BP] GO:0042542 |
response to hydrogen peroxide
|
AKR1B1, AXL, BCL2, CYP1B1, SRC |
2.48356 |
[BP] GO:0007187 |
None
|
ADORA1, ADRB1, CHRM1, CHRM2, CHRM3, CHRM5 |
2.43162 |
[BP] GO:0065007 |
biological regulation
|
ABCB1, ACHE, ADORA1, ADORA3, ADRB1, AKR1B1, ALOX12, ALOX15, APP, AURKB, AXL, BCL2, CA1, CA12, CA2, CA7, CA9, CACNA1C, CDC25B, CHRM1, CHRM2, CHRM3, CHRM5, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, EGFR, EPHX2, ERBB2, FABP3, FABP4, FLT3, HCAR2, HSD11B1, HSD17B1, HSD17B2, IGF1R, KDR, MET, MIF, MMP1, MMP2, MMP9, NR3C1, PIM1, PPARA, PRKCA, PTPN1, PTPRS, RORC, SRC, TNKS, TNKS2, TRPV1, XDH |
2.43162 |
[BP] GO:0048585 |
negative regulation of response to stimulus
|
ADORA1, ALOX12, ALOX15, BCL2, CYP19A1, EGFR, ERBB2, IGF1R, MET, MIF, MMP9, PPARA, PTPN1, PTPRS, SRC, XDH |
2.42718 |
[BP] GO:0045787 |
positive regulation of cell cycle
|
APP, AURKB, CDC25B, CYP1A1, EGFR, MIF, PRKCA, SRC |
2.41969 |
[BP] GO:0051338 |
regulation of transferase activity
|
ADORA1, APP, AURKB, CDC25B, EGFR, ERBB2, FABP4, FLT3, IGF1R, MIF, PTPN1, SRC, TNKS |
2.41558 |
[BP] GO:0043269 |
regulation of ion transport
|
ABCB1, ADORA1, APP, BCL2, CA2, CA7, CACNA1C, CHRM1, MIF, MMP9 |
2.38711 |
[BP] GO:0001503 |
ossification
|
ALOX15, BCL2, EGFR, MMP2, MMP9 |
2.38582 |
[BP] GO:0006950 |
response to stress
|
ACHE, ADORA1, ADORA3, ADRB1, AKR1B1, ALOX15, APP, AXL, BCL2, CA2, CA9, CYP1A1, CYP1A2, CYP1B1, EGFR, EPHX2, ERBB2, MIF, MMP2, MMP9, PPARA, PTPN1, SRC, TRPV1 |
2.3813 |
[BP] GO:0032880 |
regulation of protein localization
|
ACHE, APP, BCL2, CACNA1C, CHRM1, CSNK2A1, EGFR, ERBB2, HCAR2, MIF, PRKCA, PTPN1, SRC |
2.36542 |
[BP] GO:0070848 |
response to growth factor
|
APP, EGFR, ERBB2, KDR, NR3C1, SRC, TRPV1 |
2.35171 |
[BP] GO:0051047 |
None
|
ACHE, ADORA1, CYP19A1, EGFR, HCAR2, MIF, SRC, TRPV1 |
2.34175 |
[BP] GO:1904356 |
regulation of telomere maintenance via telomere lengthening
|
AURKB, SRC, TNKS, TNKS2 |
2.32863 |
[BP] GO:0034599 |
cellular response to oxidative stress
|
AKR1B1, AXL, CYP1B1, EGFR, MMP9, SRC |
2.31261 |
[BP] GO:0048511 |
rhythmic process
|
AXL, BCL2, CSNK2A1, EGFR, PPARA, RORC, SRC |
2.31261 |
[BP] GO:0010243 |
response to organonitrogen compound
|
AKR1B1, APP, EGFR, FABP3, FLT3, IGF1R, MMP2, PPARA, SRC, TRPV1, TYR |
2.28874 |
[BP] GO:0050806 |
positive regulation of synaptic transmission
|
ADORA1, APP, CA2, CA7, EGFR |
2.27981 |
[BP] GO:0009404 |
toxin metabolic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.26401 |
[BP] GO:0070213 |
None
|
TNKS, TNKS2 |
2.25547 |
[BP] GO:0097176 |
epoxide metabolic process
|
ALOX12, EPHX2 |
2.25547 |
[BP] GO:0018894 |
dibenzo-p-dioxin metabolic process
|
CYP1A1, CYP1A2 |
2.25547 |
[BP] GO:2000573 |
positive regulation of DNA biosynthetic process
|
AURKB, SRC, TNKS, TNKS2 |
2.23842 |
[BP] GO:1904951 |
positive regulation of establishment of protein localization
|
ACHE, APP, BCL2, CHRM1, EGFR, ERBB2, HCAR2, MIF, SRC |
2.23322 |
[BP] GO:0050878 |
regulation of body fluid levels
|
ADORA1, AKR1B1, ALOX12, CHRM1, CHRM3, MET, PRKCA, XDH |
2.22795 |
[BP] GO:0010634 |
positive regulation of epithelial cell migration
|
KDR, MET, MMP9, PRKCA, SRC |
2.22795 |
[BP] GO:0061900 |
None
|
APP, EGFR, TRPV1 |
2.22379 |
[BP] GO:1903409 |
reactive oxygen species biosynthetic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.22379 |
[BP] GO:0006940 |
None
|
ADORA1, CHRM1, CHRM2, CHRM3 |
2.22097 |
[BP] GO:0009636 |
response to toxic substance
|
AKR1B1, AXL, BCL2, CYP1A1, CYP1B1, EPHX2, KDR, SRC |
2.21913 |
[BP] GO:0046486 |
glycerolipid metabolic process
|
ACHE, ALOX15, CSNK2A1, EGFR, ERBB2, FABP3, FABP4, MET |
2.20709 |
[BP] GO:0051223 |
None
|
ACHE, APP, CACNA1C, CHRM1, EGFR, ERBB2, HCAR2, MIF, PRKCA, PTPN1, SRC |
2.20542 |
[BP] GO:0050790 |
regulation of catalytic activity
|
ADORA1, ADORA3, ADRB1, APP, AURKB, BCL2, CDC25B, CSNK2A1, EGFR, ERBB2, FABP4, FLT3, IGF1R, MIF, MMP9, PRKCA, PTPN1, SRC, TNKS, XDH |
2.20341 |
[BP] GO:0032101 |
regulation of response to external stimulus
|
ADORA1, ALOX12, CYP19A1, EGFR, FABP4, KDR, MET, MIF, PPARA, PRKCA, PTPRS |
2.20341 |
[BP] GO:0044093 |
positive regulation of molecular function
|
ABCB1, ADORA1, ADRB1, APP, AURKB, BCL2, CDC25B, EGFR, ERBB2, FLT3, MET, MIF, MMP9, PTPN1, SRC, TNKS, XDH |
2.20051 |
[BP] GO:0040014 |
regulation of multicellular organism growth
|
ADRB1, APP, BCL2, TNKS2 |
2.18273 |
[BP] GO:0040008 |
regulation of growth
|
ADRB1, ALOX12, APP, BCL2, CSNK2A1, EGFR, ERBB2, PIM1, PTPRS, TNKS2 |
2.18273 |
[BP] GO:0045859 |
regulation of protein kinase activity
|
ADORA1, APP, CDC25B, EGFR, ERBB2, FABP4, FLT3, IGF1R, MIF, PTPN1, SRC |
2.1812 |
[BP] GO:0051896 |
regulation of protein kinase B signaling
|
AXL, EGFR, ERBB2, MET, SRC, XDH |
2.15271 |
[BP] GO:0006706 |
steroid catabolic process
|
CYP19A1, CYP1A2, CYP3A4 |
2.14039 |
[BP] GO:1904353 |
regulation of telomere capping
|
AURKB, TNKS, TNKS2 |
2.14039 |
[BP] GO:0051054 |
positive regulation of DNA metabolic process
|
AURKB, EGFR, IGF1R, SRC, TNKS, TNKS2 |
2.13588 |
[BP] GO:0031399 |
regulation of protein modification process
|
ADORA1, ALOX15, APP, BCL2, CDC25B, EGFR, ERBB2, FABP4, FLT3, IGF1R, KDR, MIF, MMP9, PRKCA, PTPN1, SRC, XDH |
2.13548 |
[BP] GO:0050801 |
ion homeostasis
|
APP, BCL2, CA12, CA2, CA7, CACNA1C, EGFR, EPHX2, FABP3, TRPV1 |
2.10761 |
[BP] GO:1904357 |
None
|
SRC, TNKS, TNKS2 |
2.10009 |
[BP] GO:0009892 |
negative regulation of metabolic process
|
ADORA1, APP, AURKB, BCL2, CSNK2A1, EGFR, FABP4, HCAR2, IGF1R, KDR, MET, MIF, MMP9, NR3C1, PPARA, PRKCA, PTPN1, RORC, SRC, TNKS, TNKS2, TRPV1, XDH |
2.0988 |
[BP] GO:0031099 |
regeneration
|
AXL, BCL2, CSNK2A1, EGFR, FLT3 |
2.09354 |
[BP] GO:1903725 |
regulation of phospholipid metabolic process
|
CHRM5, FABP3, FLT3, SRC |
2.08838 |
[BP] GO:0048545 |
response to steroid hormone
|
BCL2, CA2, EGFR, FLT3, NR3C1, SRC |
2.08838 |
[BP] GO:0046541 |
None
|
CHRM1, CHRM3 |
2.08838 |
[BP] GO:0051122 |
hepoxilin biosynthetic process
|
ALOX12, ALOX15 |
2.08838 |
[BP] GO:0051121 |
hepoxilin metabolic process
|
ALOX12, ALOX15 |
2.08838 |
[BP] GO:0051247 |
positive regulation of protein metabolic process
|
ADORA1, ALOX15, APP, BCL2, CDC25B, CSNK2A1, EGFR, ERBB2, FLT3, KDR, MIF, MMP9, PRKCA, PTPN1, SRC, XDH |
2.07433 |
[BP] GO:0033032 |
regulation of myeloid cell apoptotic process
|
BCL2, HCAR2, MIF |
2.06687 |
[BP] GO:1901698 |
response to nitrogen compound
|
AKR1B1, APP, EGFR, FABP3, FLT3, IGF1R, MMP2, PPARA, SRC, TRPV1, TYR |
2.06066 |
[BP] GO:0071495 |
cellular response to endogenous stimulus
|
AKR1B1, APP, EGFR, ERBB2, FLT3, IGF1R, MMP2, NR3C1, SRC, TRPV1 |
2.05781 |
[BP] GO:0071383 |
None
|
EGFR, FLT3, NR3C1, SRC |
2.05394 |
[BP] GO:0051347 |
positive regulation of transferase activity
|
ADORA1, AURKB, CDC25B, EGFR, ERBB2, FLT3, MIF, PTPN1, SRC, TNKS |
2.05208 |
[BP] GO:0001101 |
response to acid chemical
|
AKR1B1, EGFR, FABP3, HSD17B2, KDR, MMP2, SRC |
2.05106 |
[BP] GO:0006636 |
unsaturated fatty acid biosynthetic process
|
ALOX12, ALOX15, MIF |
2.03495 |
[BP] GO:0031100 |
animal organ regeneration
|
AXL, CSNK2A1, EGFR, FLT3 |
2.01932 |
[BP] GO:0048661 |
positive regulation of smooth muscle cell proliferation
|
AKR1B1, EGFR, MMP2, MMP9 |
2.01932 |
[BP] GO:0044283 |
None
|
AKR1B1, ALOX12, ALOX15, ALOX5, CYP19A1, CYP1A1, CYP3A4, MIF |
2.01835 |
[BP] GO:0090257 |
None
|
ADORA1, CACNA1C, CHRM1, CHRM2, CHRM3, PRKCA |
2.01719 |
[BP] GO:0042060 |
None
|
ALOX15, EGFR, ERBB2, PPARA |
2.00167 |
[CC] GO:0016020 |
membrane
|
ABCB1, ACHE, ADORA1, ADORA3, ADRB1, ALOX12, ALOX15, ALOX5, APP, AXL, BCL2, CA12, CA14, CA2, CA4, CA9, CACNA1C, CHRM1, CHRM2, CHRM3, CHRM5, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, EGFR, ERBB2, FLT3, FUT7, HCAR2, HSD11B1, HSD17B2, IGF1R, KDR, MET, MMP2, PIM1, PRKCA, PTPN1, PTPRS, SRC, TNKS, TNKS2, TRPV1, TYR |
4.4555 |
[CC] GO:0005886 |
plasma membrane
|
ABCB1, ACHE, ADORA1, ADORA3, ADRB1, ALOX12, ALOX15, APP, AXL, CA12, CA14, CA2, CA4, CA9, CACNA1C, CHRM1, CHRM2, CHRM3, CHRM5, CSNK2A1, EGFR, ERBB2, FLT3, HCAR2, IGF1R, KDR, MET, MMP2, PIM1, PRKCA, PTPN1, PTPRS, SRC, TRPV1 |
3.68115 |
[CC] GO:0016323 |
basolateral plasma membrane
|
ADORA1, CA2, CA4, CA9, CHRM3, EGFR, ERBB2 |
3.28892 |
[CC] GO:0044444 |
cytoplasmic part
|
ACHE, ADORA1, ADRB1, AKR1B1, AKR1B10, ALOX12, ALOX15, ALOX5, APP, AURKB, BCL2, CA1, CA2, CA4, CA7, CACNA1C, CBR1, CDC25B, CHRM2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, EGFR, EPHX2, ERBB2, FABP3, FABP4, FLT3, FUT7, HSD11B1, HSD17B1, HSD17B2, KDR, MIF, MMP2, MMP9, NR3C1, PIM1, PRKCA, PTPN1, PTPRS, SRC, TNKS, TNKS2, TRPV1, TYR, XDH |
3.28351 |
[CC] GO:0098590 |
plasma membrane region
|
ABCB1, ADORA1, CA2, CA4, CA9, CHRM1, CHRM2, CHRM3, CHRM5, EGFR, ERBB2, MET, SRC, TRPV1 |
3.12964 |
[CC] GO:0044459 |
plasma membrane part
|
ABCB1, ADORA1, ADORA3, ADRB1, ALOX15, APP, AXL, CA2, CA4, CA9, CACNA1C, CHRM1, CHRM2, CHRM3, CHRM5, EGFR, ERBB2, FLT3, IGF1R, KDR, MET, PTPRS, SRC, TRPV1 |
3.10973 |
[CC] GO:0044425 |
membrane part
|
ABCB1, ACHE, ADORA1, ADORA3, ADRB1, ALOX15, APP, AXL, BCL2, CA12, CA14, CA2, CA4, CA9, CACNA1C, CHRM1, CHRM2, CHRM3, CHRM5, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, EGFR, ERBB2, FLT3, FUT7, HCAR2, HSD11B1, HSD17B2, IGF1R, KDR, MET, PTPN1, PTPRS, SRC, TRPV1, TYR |
2.79785 |
[CC] GO:0044456 |
None
|
ACHE, ADORA1, APP, CACNA1C, CHRM1, CHRM2, CHRM3, CHRM5, PTPRS, SRC, TRPV1 |
2.58543 |
[CC] GO:0045202 |
None
|
ACHE, APP, CHRM1, CHRM2, CHRM3, CHRM5, EGFR |
2.50397 |
[CC] GO:0031226 |
intrinsic component of plasma membrane
|
ADORA1, ADORA3, ADRB1, APP, AXL, CA4, CHRM1, CHRM2, CHRM3, CHRM5, FLT3, IGF1R, KDR, MET, PTPRS, TRPV1 |
2.48356 |
[CC] GO:0048471 |
perinuclear region of cytoplasm
|
ACHE, AKR1B1, APP, CA4, EGFR, ERBB2, PRKCA, SRC, TNKS2, TYR |
2.20974 |
[CC] GO:0005887 |
integral component of plasma membrane
|
ADORA1, ADORA3, ADRB1, APP, AXL, CHRM1, CHRM2, CHRM3, CHRM5, FLT3, IGF1R, KDR, MET, PTPRS, TRPV1 |
2.18273 |
[CC] GO:0044432 |
endoplasmic reticulum part
|
APP, BCL2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, EGFR, FLT3, HSD11B1, HSD17B2, PTPN1 |
2.04725 |
[MF] GO:0046914 |
transition metal ion binding
|
ALOX12, ALOX15, ALOX5, APP, CA1, CA12, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, MMP1, MMP2, MMP9, NR3C1, PIM1, PPARA, PRKCA, PTPN1, RORC, TNKS, TYR, XDH |
14.0166 |
[MF] GO:0003824 |
catalytic activity
|
ABCB1, ACHE, ADORA1, AKR1B1, AKR1B10, ALOX12, ALOX15, ALOX5, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CBR1, CDC25B, CHRM1, CHRM3, CHRM5, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, EGFR, EPHX2, ERBB2, FLT3, FUT7, HSD11B1, HSD17B1, HSD17B2, IGF1R, KDR, MET, MIF, MMP1, MMP2, MMP9, PIM1, PRKCA, PTPN1, PTPRS, SRC, TNKS, TNKS2, TUBB3, TYR, XDH |
12.9383 |
[MF] GO:0004089 |
carbonate dehydratase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
9.90099 |
[MF] GO:0043167 |
ion binding
|
ABCB1, ACHE, ALOX12, ALOX15, ALOX5, APP, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CACNA1C, CHRM3, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, EGFR, EPHX2, ERBB2, FABP3, FABP4, FLT3, HSD17B1, IGF1R, KDR, MET, MMP1, MMP2, MMP9, NR3C1, PIM1, PPARA, PRKCA, PTPN1, PTPRS, RORC, SRC, TNKS, TNKS2, TRPV1, TUBB3, TYR, XDH |
9.86332 |
[MF] GO:0016712 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4 |
8.29273 |
[MF] GO:0005506 |
iron ion binding
|
ALOX12, ALOX15, ALOX5, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, XDH |
7.87952 |
[MF] GO:0016491 |
oxidoreductase activity
|
AKR1B1, AKR1B10, ALOX12, ALOX15, ALOX5, CBR1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, HSD11B1, HSD17B1, HSD17B2, TYR, XDH |
7.30224 |
[MF] GO:0070330 |
aromatase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP3A4 |
6.89484 |
[MF] GO:0008144 |
drug binding
|
ABCB1, ACHE, AURKB, AXL, CHRM1, CHRM2, CHRM3, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP3A4, EGFR, ERBB2, FLT3, IGF1R, KDR, MET, PIM1, PPARA, PRKCA, SRC, TRPV1 |
6.62765 |
[MF] GO:0016907 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5 |
6.33523 |
[MF] GO:0016836 |
hydro-lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
6.26847 |
[MF] GO:0004497 |
monooxygenase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, TYR |
6.08454 |
[MF] GO:0004714 |
transmembrane receptor protein tyrosine kinase activity
|
AXL, EGFR, ERBB2, FLT3, IGF1R, KDR, MET |
5.95353 |
[MF] GO:0043169 |
cation binding
|
ACHE, ALOX12, ALOX15, ALOX5, APP, AURKB, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CACNA1C, CHRM3, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, EPHX2, MMP1, MMP2, MMP9, NR3C1, PIM1, PPARA, PRKCA, PTPN1, RORC, TNKS, TNKS2, TRPV1, TYR, XDH |
5.71179 |
[MF] GO:0016835 |
carbon-oxygen lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
5.50625 |
[MF] GO:0019825 |
oxygen binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP3A4 |
5.39457 |
[MF] GO:0019199 |
transmembrane receptor protein kinase activity
|
AXL, EGFR, ERBB2, FLT3, IGF1R, KDR, MET |
5.38372 |
[MF] GO:0020037 |
heme binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, SRC |
5.25586 |
[MF] GO:0046906 |
tetrapyrrole binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, SRC |
5.05209 |
[MF] GO:0046872 |
metal ion binding
|
ALOX12, ALOX15, ALOX5, APP, AURKB, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CACNA1C, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, EPHX2, MMP1, MMP2, MMP9, NR3C1, PIM1, PPARA, PRKCA, PTPN1, RORC, TNKS, TNKS2, TRPV1, TYR, XDH |
4.91096 |
[MF] GO:0016705 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, TYR |
4.70031 |
[MF] GO:0008270 |
zinc ion binding
|
CA1, CA12, CA2, CA4, CA7, CA9, MMP1, MMP2, MMP9, NR3C1, PPARA, PRKCA, PTPN1, RORC, TNKS |
4.53903 |
[MF] GO:0008395 |
steroid hydroxylase activity
|
CYP19A1, CYP1A1, CYP2A13, CYP2A6, CYP3A4 |
4.52353 |
[MF] GO:0038023 |
signaling receptor activity
|
ADORA1, ADORA3, ADRB1, AXL, CHRM1, CHRM2, CHRM3, CHRM5, EGFR, ERBB2, FLT3, HCAR2, IGF1R, KDR, MET, NR3C1, PPARA, RORC, TRPV1 |
4.41991 |
[MF] GO:0004713 |
protein tyrosine kinase activity
|
AXL, EGFR, ERBB2, FLT3, IGF1R, KDR, MET, SRC |
4.31321 |
[MF] GO:0015464 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5 |
4.09027 |
[MF] GO:0016614 |
oxidoreductase activity, acting on CH-OH group of donors
|
AKR1B1, AKR1B10, CBR1, HSD11B1, HSD17B1, HSD17B2, XDH |
4.02798 |
[MF] GO:0042562 |
hormone binding
|
ACHE, CHRM3, EGFR, HSD17B1, IGF1R, NR3C1 |
4.00847 |
[MF] GO:0004872 |
receptor activity
|
ADORA1, ADORA3, ADRB1, AXL, CHRM1, CHRM2, CHRM3, CHRM5, EGFR, ERBB2, FLT3, HCAR2, IGF1R, KDR, MET, NR3C1, PPARA, RORC, TRPV1 |
3.75005 |
[MF] GO:0008227 |
None
|
ADRB1, CHRM1, CHRM2, CHRM3, CHRM5 |
3.59032 |
[MF] GO:0060089 |
molecular transducer activity
|
ADORA1, ADORA3, ADRB1, AXL, CHRM1, CHRM2, CHRM3, CHRM5, EGFR, ERBB2, FLT3, HCAR2, IGF1R, KDR, MET, NR3C1, PPARA, RORC, TRPV1 |
3.59032 |
[MF] GO:0004672 |
protein kinase activity
|
AURKB, AXL, CSNK2A1, EGFR, ERBB2, FLT3, IGF1R, KDR, MET, PIM1, PRKCA, SRC |
3.4327 |
[MF] GO:0016725 |
oxidoreductase activity, acting on CH or CH2 groups
|
CYP1A2, CYP3A4, XDH |
3.33875 |
[MF] GO:0016803 |
ether hydrolase activity
|
ALOX12, ALOX15, EPHX2 |
3.33875 |
[MF] GO:0004716 |
signal transducer, downstream of receptor, with protein tyrosine kinase activity
|
EGFR, ERBB2, KDR |
3.33875 |
[MF] GO:0004629 |
None
|
ADORA1, CHRM1, CHRM3, CHRM5 |
3.32414 |
[MF] GO:0016829 |
lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
3.31358 |
[MF] GO:0016616 |
oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor
|
AKR1B1, AKR1B10, CBR1, HSD11B1, HSD17B1, HSD17B2 |
3.30589 |
[MF] GO:0004871 |
signal transducer activity
|
ADORA1, ADORA3, ADRB1, AXL, CHRM1, CHRM2, CHRM3, CHRM5, EGFR, ERBB2, FLT3, HCAR2, IGF1R, KDR, MET, NR3C1, PPARA, RORC, TRPV1 |
3.25375 |
[MF] GO:0099600 |
transmembrane receptor activity
|
ADORA1, ADORA3, ADRB1, AXL, CHRM1, CHRM2, CHRM3, CHRM5, EGFR, ERBB2, FLT3, HCAR2, IGF1R, KDR, MET, TRPV1 |
3.20205 |
[MF] GO:0004888 |
transmembrane signaling receptor activity
|
ADORA1, ADORA3, ADRB1, AXL, CHRM1, CHRM2, CHRM3, CHRM5, EGFR, ERBB2, FLT3, HCAR2, IGF1R, KDR, MET, TRPV1 |
3.20205 |
[MF] GO:0048037 |
cofactor binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, HSD17B1, SRC, XDH |
3.10973 |
[MF] GO:0016801 |
None
|
ALOX12, ALOX15, EPHX2 |
3.02502 |
[MF] GO:0099528 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5 |
3.00776 |
[MF] GO:0047977 |
hepoxilin-epoxide hydrolase activity
|
ALOX12, ALOX15 |
2.91966 |
[MF] GO:0008389 |
None
|
CYP2A13, CYP2A6 |
2.91966 |
[MF] GO:0016773 |
phosphotransferase activity, alcohol group as acceptor
|
AURKB, AXL, CSNK2A1, EGFR, ERBB2, FLT3, IGF1R, KDR, MET, PIM1, PRKCA, SRC |
2.78891 |
[MF] GO:0019902 |
phosphatase binding
|
BCL2, EGFR, ERBB2, MET, PPARA, PTPN1 |
2.6472 |
[MF] GO:0070576 |
vitamin D 24-hydroxylase activity
|
CYP1A1, CYP3A4 |
2.50397 |
[MF] GO:0004052 |
arachidonate 12-lipoxygenase activity
|
ALOX12, ALOX15 |
2.50397 |
[MF] GO:0051120 |
hepoxilin A3 synthase activity
|
ALOX12, ALOX15 |
2.50397 |
[MF] GO:0016301 |
kinase activity
|
AURKB, AXL, CSNK2A1, EGFR, ERBB2, FLT3, IGF1R, KDR, MET, PIM1, PRKCA, SRC |
2.47059 |
[MF] GO:0042578 |
None
|
ADORA1, CDC25B, CHRM1, CHRM3, CHRM5, EPHX2, PTPN1, PTPRS |
2.45468 |
[MF] GO:0019903 |
protein phosphatase binding
|
BCL2, EGFR, ERBB2, MET, PTPN1 |
2.3239 |
[MF] GO:0016788 |
None
|
ACHE, ADORA1, CA1, CA2, CDC25B, CHRM1, CHRM3, CHRM5, EPHX2, PTPN1, PTPRS |
2.32003 |
[MF] GO:0034875 |
caffeine oxidase activity
|
CYP1A2, CYP3A4 |
2.25547 |
[MF] GO:0033695 |
oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor
|
CYP1A2, CYP3A4 |
2.25547 |
[MF] GO:0016702 |
oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen
|
ALOX12, ALOX15, ALOX5 |
2.14039 |
[MF] GO:0004435 |
None
|
CHRM1, CHRM3, CHRM5 |
2.10009 |
[MF] GO:0033764 |
steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor
|
HSD11B1, HSD17B1, HSD17B2 |
2.10009 |
[MF] GO:0016701 |
oxidoreductase activity, acting on single donors with incorporation of molecular oxygen
|
ALOX12, ALOX15, ALOX5 |
2.10009 |
[MF] GO:0101020 |
estrogen 16-alpha-hydroxylase activity
|
CYP1A1, CYP3A4 |
2.08838 |
[MF] GO:0008289 |
lipid binding
|
ALOX15, AXL, CYP3A4, FABP3, FABP4, HSD17B1, NR3C1, PPARA, RORC, TRPV1 |
2.08838 |
[MF] GO:0042802 |
identical protein binding
|
ACHE, APP, BCL2, CSNK2A1, EGFR, EPHX2, ERBB2, FLT3, IGF1R, KDR, MET, MIF, MMP9, TRPV1, TYR, XDH |
2.05781 |
[MF] GO:0043168 |
anion binding
|
ABCB1, ALOX15, APP, AURKB, AXL, CSNK2A1, EGFR, ERBB2, FABP3, FABP4, FLT3, HSD17B1, IGF1R, KDR, MET, PIM1, PRKCA, PTPRS, SRC, TRPV1, TUBB3, XDH |
2.05394 |
[MF] GO:0019899 |
enzyme binding
|
ADRB1, APP, AURKB, BCL2, CDC25B, CYP1A1, CYP1A2, CYP2A6, CYP3A4, EGFR, ERBB2, MET, MIF, NR3C1, PPARA, PRKCA, PTPN1, SRC, TNKS2 |
2.04909 |
[MF] GO:0016229 |
steroid dehydrogenase activity
|
HSD11B1, HSD17B1, HSD17B2 |
2.03495 |
[MF] GO:0044877 |
macromolecular complex binding
|
ACHE, ADORA1, CSNK2A1, EGFR, FLT3, IGF1R, KDR, MMP9, PIM1, PPARA, PTPN1, SRC |
2.00167 |